INTRODUCTION
============

Portal vein thrombosis (PVT) is an extremely rare complication after abdominal surgery. We report what is believed to be the fourth reported case and youngest reported patient with left PVT after laparoscopic cholecystectomy (LC). PVT after laparoscopic surgery is extremely rare but should be included in the differential diagnosis of unexplained abdominal pain after laparoscopic cholecystectomy.

CASE REPORT
===========

The patient was a 31-year-old woman who presented initially to our service with a 6-month history of recurrent postprandial right upper quadrant pain. Her past medical history was remarkable for hypertension (which developed during pregnancy) and thyroid nodules, and she had undergone cesarean section 7 months previously. She had no remarkable family history of hypercoagulable state or thrombotic events. She was taking metoprolol and methyldopa daily to treat her hypertension. She was not taking oral contraceptive pills. Abdominal ultrasonography showed cholelithiasis without other abnormal findings. Her preoperative liver function tests showed normal transaminases (alanine aminotransferase 20 U/L, aspartate aminotransferase 13 U/L), alkaline phosphatase (95 U/L), and total bilirubin (0.3 mg/dL). Preoperative coagulation parameters were all normal. She underwent an uneventful elective laparoscopic cholecystectomy and was discharged home on the same day. Pathologic results were consistent with chronic cholecystitis.

At postoperative day 10, the patient re-presented to our emergency center complaining of right flank pain and nausea. She was afebrile and nontachycardic. Physical examination demonstrated minimal abdominal tenderness. Her laboratory results were remarkable for elevated transaminases (alanine aminotransferase 271 U/L, aspartate aminotransferase 466 U/L), alkaline phosphatase (219 U/L), and total bilirubin (1.1 mg/dL). Abdominal ultrasonography revealed, somewhat unexpectedly, left PVT **([Figure 1](#F1){ref-type="fig"})**, which was confirmed with a computed tomography (CT) scan of the abdomen **([Figure 2](#F2){ref-type="fig"})**. She was admitted to our service. A hypercoagulable workup demonstrated a low protein S (35%, range 60--120). Her protein C was normal. Anticardiolipin antibiodies (IgA, IgG, and IgM) were all within normal limits. There was no evidence of a factor II (prothrombin) G20210A mutation, factor V Leiden mutation, or JAK2 V617F mutation. She was started on therapeutic low-molecular-weight heparin (LMWH, enoxaparin). She responded to the treatment with improved liver function tests and resolved abdominal symptoms. She was discharged in good condition on hospital day 3 with therapeutic LMWH and oral warfarin and was expected to continue taking therapeutic anticoagulation medication.

![Ultrasound demonstrating left PVT (arrow).](jls0021330080001){#F1}

![Computed tomography of the abdomen demonstrating left PVT (arrow).](jls0021330080002){#F2}

DISCUSSION
==========

PVT is a recognized complication after laparoscopic procedures including Roux-en-Y gastric bypass, Nissen fundoplication, partial colectomy, cholecystectomy, and appendectomy.^[@B1]^ Although rare, there are three cases reported in the English language literature of PVT after laparoscopic cholecystectomy.^[@B2][@B3][@B4]^ All patients, including our patient, underwent what was described as uncomplicated laparoscopic cholecystectomy.

Formation of PVT in these patients is likely multifactorial. Pneumoperitoneum and the resultant increased intra-abdominal pressure has been shown to result in changes in coagulation parameters,^[@B2]^ as manifested by changes in prothrombin time, international normalized ratio, D-dimer, fibrinogen, and fibrin degradation products.^[@B5]^ Pneumoperitoneum also affects splanchnic and portal venous blood flow.^[@B2]^ One study demonstrated that the diameter of the portal venous trunk and the mean portal blood flow were significantly decreased with pneumoperitoneum of \>10 mm Hg.^[@B6]^ Patient positioning during laparoscopic surgery may also affect portal blood flow and stasis.^[@B1]^ Direct injury to the portal venous system may also be a contributing factor but is unlikely in our case because of the anatomy of the portal vein as a posterior structure. Another significant factor in PVT is underlying coagulopathy and underlying patient disease processes. All previously reported cases have demonstrated some hypercoagulable state **([Table 1](#T1){ref-type="table"}).** Our patient had low protein S, which may have contributed to her hyperocoagulable state. It is important to note, however, that in some cases, low protein S may be associated with acute thrombosis and not be reflective of a true hypercoagulable state.^[@B7]^ In all cases, the contributing coagulopathy was not detected preoperatively.

###### 

Review of All Reported Cases[\*](#TF1-1){ref-type="table-fn"} of PVT After Laparoscopic Cholecystectomy

  Report                                      Age/Gender   Indication              Risk Factors                        Coagulopathy                               Presentation                               Findings                   Treatment
  ------------------------------------------- ------------ ----------------------- ----------------------------------- ------------------------------------------ ------------------------------------------ -------------------------- ------------------------------------------------
  Ourania et al., 2005                        32/F         Gallbladder polyps      Oral contraceptive pills            Elevated anticardiolipin antibody (IgG)    POD 7: abdominal pain and ileus            Superior mesenteric vein   Transhepatic portal vein thrombectomy, heparin
  Preoperative: SCD, unfractionated heparin                                                                                                                                                                                             
  Dilip et al., 2011                          63/F         Chronic cholecystitis   Diabetes, coronary artery disease   Dengue viral infection                     POD 5: nausea, emesis, and diarrhea        Main portal vein           Intravenous hydration, antibiotics
  Preoperative: unknown                                                                                                                                                                                                                 
  Waheed et al., 2012                         55/F         Chronic cholecystitis   None                                Factor II (prothrombin) G20210A mutation   2 months postoperatively: abdominal pain   Portal/splenic vein        Low-molecular-weight heparin
  Preoperative: unknown                                                                                                                                                                                                                 
  Current Report                              31/F         Chronic cholecystitis   Hypertension                        Low protein S                              POD 10: abdominal pain and nausea          Left portal vein           Low-molecular-weight heparin and warfarin
  Preoperative: SCD                                                                                                                                                                                                                     

POD = postoperative day; SCD = sequential compression devices.

Includes the present report.

The diagnosis of PVT can be established with ultrasonography or computed tomography with intravenous contrast, both commonly used in the workup of unexplained pain and symptoms after laparoscopic cholecystectomy. Other adjuncts, including angiography and magnetic resonance imaging, may also be used. The treatment varies depending on the extent of the thrombosis and the presence or absence of bowel ischemia. It is unknown whether preoperative antithrombotic prophylaxis affects the incidence of PVT.^[@B1]^ One patient required transhepatic portal vein thrombectomy for significant thrombosis, but most patients who present with PVT after laparoscopic procedures require only supportive treatment and anticoagulation. Our patient promptly improved after initiation of LMWH and was discharged on hospital day 3 with an LMWH-to-warfarin bridge. The optimal duration of anticoagulation for these patients is unknown.^[@B3]^ If the patient has primary coagulation disorders, lifelong anticoagulation is required. For those with no identifiable risk factors, some suggest it is reasonable to re-image the patient after approximately 6 months of anticoagulation and stop if resolution of the thrombosis is documented.

CONCLUSION
==========

Albeit extremely rare, PVT should be included in the differential diagnosis for abdominal symptoms and/or elevated hepatic function tests after laparoscopic cholecystectomy.
